Top Three Disconnects in Product Development
LISTEN to the roundtable discussion: “MedTech Product Development: Getting the Right Products to Market Sooner”From bringing together a variety of roles and responsibilities within an organization to trying to keep an eye on the big picture, managing the product development process is not for the faint of heart. MedTech Intelligence asked readers to tell us the areas in which they experience the most problematic disconnects during the product development process. Below are the results.
| Register for the MedTech Product Development Conference in-person or virtually! September 29-30, 2016. |
Top three product development disconnects:
- Regulatory pathway planning
- Aligning engineering and clinical considerations
- From user needs to design
| Where are the most problematic process disconnects in product development? |
Responses |
| From user needs to design | 42% |
| Design to testing | 17% |
| Integrating hardware and software | 29% |
| Communication with service or component vendors | 12% |
| Aligning engineering and clinical considerations | 51% |
| From early design to prototyping | 7% |
| From prototyping to manufacturing | 32% |
| Aligning business objectives with user needs | 39% |
| Managing design changes | 32% |
| Reimbursement due diligence | 27% |
| Regulatory pathway planning | 46% |
| Table I. Results from a recent product development survey conducted by MedTech Intelligence. | |
Related Articles
-
And the bigger question might be: How well do you really know them?
-
The evaluation and management of risk throughout the product life cycle is the single most important concept in the regulation of medical devices. Yet it is difficult to define precisely what “risk” means or how to assess it in an…
-
Device manufacturers must do more to integrate supplier and clinical perspectives during the product design process.
-
The acquisition brings MAXIS’ expertise in pre-clinical engineering, design validation and verification, regulatory affairs, field clinical services, and trial management to Avania’s contract research and MedTech development capabilities.
